Correction: Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin

Yingwei Zhang; Zeyu Zhang; Chundi Li; Donge Tang; Yong Dai

doi:10.1039/d3mo90012f

Correction: Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin

Mol Omics. 2023 May 9;19(4):362. doi: 10.1039/d3mo90012f.

Authors

Yingwei Zhang¹, Zeyu Zhang², Chundi Li¹, Donge Tang², Yong Dai²

Affiliations

¹ Department of Nephrology, Shenzhen Longhua District Central Hospital, Shenzhen 518000, China. 18653133290zyw@sina.com.
² The Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen 518020, China. daiyong22@163.com.

PMID: 37070329
DOI: 10.1039/d3mo90012f

Abstract

Correction for 'Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin' by Yingwei Zhang et al., Mol. Omics, 2022, 18, 643-651, https://doi.org/10.1039/D2MO00036A.

Publication types

Published Erratum